MYOKARDIA INC

Profile

Company Names

MYOKARDIA INC

Addresses

333 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA 94080

400 EAST JAMIE COURT, SUITE 102, SOUTH SAN FRANCISCO, CA 94080

455 MISSION BAY BLVD SOUTH, SUITE 575, SAN FRANCISCO, CA 94158

Phone Numbers

650-741-0900
415-766-3638

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$60,000,660.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2015-04-20 
$46,000,001.00 
$46,000,001.00 
$0.00 
Equity 
4
2014-08-01 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
3
2012-09-11 
$4,000,000.00 
$38,000,000.00 
$34,000,000.00 
Equity 
2
2012-08-09 
$459.00 
$459.00 
$0.00 
Equity 
1
2012-06-21 
$200.00 
$200.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KATHERINE 
 
BOWDISH 
DIRECTOR
MYOKARDIA INC   |  PORTAL INSTRUMENTS, INC.   |  THERMALIN INC.
TASSOS 
ANASTASIOS 
GIANAKAKOS 
EXECUTIVE OFFICER, DIRECTOR
MYOKARDIA INC
CHARLES 
 
HOMCY 
EXECUTIVE OFFICER, DIRECTOR
PORTOLA PHARMACEUTICALS INC   |  CYTOMX THERAPEUTICS, INC.   |  MYOKARDIA INC   |  PLIANT THERAPEUTICS, INC.   |  FAZE MEDICINES, INC.
MARK 
 
PERRY 
DIRECTOR
AEROVANCE INC   |  NEWSCALE INC   |  GLACIER BAY, INC.   |  PROSTOR SYSTEMS INC   |  PATHWAY THERAPEUTICS, INC.   |  MYOKARDIA INC   |  WILSHIRE MNCPPC EMPLOYEES- RETIREMENT SYSTEM GLOBAL, L.P. (SERIES II)   |  III CONVEX STRATEGIES FUND LTD.   |  III FUND LP   |  III RELATIVE VALUE CREDIT STRATEGIES FUND L P   |  III SELECT CREDIT FUND LTD   |  III SELECT CREDIT FUND LP   |  III RELATIVE VALUE CREDIT STRATEGIES FUND LTD   |  III FUND LTD.   |  III CREDIT OPPORTUNITIES FUND L.P.   |  III CREDIT OPPORTUNITIES FUND LTD.   |  III CONVEX STRATEGIES HUB FUND LTD.   |  III EP CREDIT STRATEGIES ERISA SP, A SEGREGATED PORTFOLIO OF III EP STRATEGIES SPC   |  III GOVERNMENT RELATIVE VALUE FUND LTD.   |  III CRE BRIDGE LOAN FUND L.P.   |  III EP TAIL STRATEGIES SP, A SEGREGATED PORTFOLIO OF III EP STRATEGIES SPC   |  III EP STRATEGIES FUND LTD.   |  III CONVEX STRATEGIES FUND L.P.   |  WILSHIRE MNCPPC EMPLOYEES- RETIREMENT SYSTEM GLOBAL, L.P. (SERIES III)
KEVIN 
 
STARR 
DIRECTOR
AFFERENT PHARMACEUTICALS, INC.   |  ZAFGEN, INC.   |  AGIOS PHARMACEUTICALS INC   |  PANOPTICA, INC.   |  MYOKARDIA INC   |  THIRD ROCK VENTURES III, L.P.   |  SAGE THERAPEUTICS, INC.   |  GLOBAL BLOOD THERAPEUTICS, INC.   |  DECIBEL THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-04-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-20 
2014-08-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-01 
2012-10-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-09-11 
2012-10-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-09 
2012-07-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#